Multicenter and all-comers validation of a score to select patients for manual thrombectomy, the DDTA score.
STEMI
primary angioplasty
thrombectomy
Journal
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
ISSN: 1522-726X
Titre abrégé: Catheter Cardiovasc Interv
Pays: United States
ID NLM: 100884139
Informations de publication
Date de publication:
09 2021
09 2021
Historique:
revised:
08
03
2021
received:
13
01
2021
accepted:
24
03
2021
pubmed:
9
4
2021
medline:
21
10
2021
entrez:
8
4
2021
Statut:
ppublish
Résumé
Routine manual thrombectomy (MT) is not recommended in primary percutaneous coronary intervention (P-PCI) but it is performed in many procedures. The objective of our study was validating the DDTA score, designed for selecting patients who benefit most from MT. Observational and multicenter study of all consecutive patients undergoing P-PCI in five institutions. Results were compared with the design cohort and the performance of the DDTA was analyzed in all patients. Primary end-point of the analyses was TIMI 3 after MT; secondary endpoints were final TIMI 3, no-reflow incidence, in-hospital mortality and in-hospital major cardiovascular events (MACE). In-hospital prognosis was assessed by the Zwolle risk score. Three hundred forty patients were included in the validation cohort and no differences were observed as compared to the design cohort (618 patients) except for lower use of MT and higher IIb/IIIa inhibitors or drug-eluting stents. The probability of TIMI 3 after MT decreased as delay to P-PCI was higher. If DDTA score, MT was associated to TIMI 3 after MT (OR: 4.11) and final TIMI 3 (OR: 2.44). There was a linear and continuous relationship between DDTA score and all endpoints. DDTA score ≥ 4 was independently associated to lower no-reflow, in-hospital MACE or mortality. The lowest incidence of in-hospital mortality or MACE was in patients who had DDTA score ≥ 4 and Zwolle risk score 0-3. MT is associated to higher rate of final TIMI3 in patients with the DDTA score ≥ 4. Patients with DDTA score ≥ 4 had lower no-reflow and in-hospital complications.
Sections du résumé
BACKGROUND
Routine manual thrombectomy (MT) is not recommended in primary percutaneous coronary intervention (P-PCI) but it is performed in many procedures. The objective of our study was validating the DDTA score, designed for selecting patients who benefit most from MT.
METHODS
Observational and multicenter study of all consecutive patients undergoing P-PCI in five institutions. Results were compared with the design cohort and the performance of the DDTA was analyzed in all patients. Primary end-point of the analyses was TIMI 3 after MT; secondary endpoints were final TIMI 3, no-reflow incidence, in-hospital mortality and in-hospital major cardiovascular events (MACE). In-hospital prognosis was assessed by the Zwolle risk score.
RESULTS
Three hundred forty patients were included in the validation cohort and no differences were observed as compared to the design cohort (618 patients) except for lower use of MT and higher IIb/IIIa inhibitors or drug-eluting stents. The probability of TIMI 3 after MT decreased as delay to P-PCI was higher. If DDTA score, MT was associated to TIMI 3 after MT (OR: 4.11) and final TIMI 3 (OR: 2.44). There was a linear and continuous relationship between DDTA score and all endpoints. DDTA score ≥ 4 was independently associated to lower no-reflow, in-hospital MACE or mortality. The lowest incidence of in-hospital mortality or MACE was in patients who had DDTA score ≥ 4 and Zwolle risk score 0-3.
CONCLUSIONS
MT is associated to higher rate of final TIMI3 in patients with the DDTA score ≥ 4. Patients with DDTA score ≥ 4 had lower no-reflow and in-hospital complications.
Substances chimiques
DDTA
80480-43-9
Edetic Acid
9G34HU7RV0
Types de publication
Journal Article
Multicenter Study
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
E342-E350Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
Levine GN, Bates ER, Blankenship JC, et al. 2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. J Am Coll Cardiol. 2016;67(10):1235-1250.
Ibanez B, James S, Agewall S, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2017;39(2):119-177.
Juan JR, Vladimir D, John AC, et al. An international survey of clinical practice during primary percutaneous coronary intervention for ST-elevation myocardial infarction with a focus on aspiration thrombectomy. EuroIntervention. 2013;8(10):1143-1148.
Sirker A, Mamas M, Kwok CS, Kontopantelis E, Ludman P, Hildick-Smith D. Outcomes from selective use of thrombectomy in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an analysis of the British cardiovascular intervention society/National Institute for cardiovascular outcomes research (BCIS-NICOR) registry, 2006-2013. J Am Coll Cardiol Intv. 2016;9(2):126-134.
Secemsky EA, Ferro EG, Rao SV, et al. Association of physician variation in use of manual aspiration thrombectomy with outcomes following primary percutaneous coronary intervention for ST-elevation myocardial infarction: the National Cardiovascular Data Registry CathPCI RegistryOperator variation in aspiration ThrombectomyOperator variation in aspiration thrombectomy. JAMA Cardiol. 2019;4(2):110-118.
Luz A, Silveira I, Brochado B, et al. Manual thrombectomy efficiency in relationship to the area at risk in patients with myocardial infarction with TIMI 0-1 coronary flow: insights from an all comers registry. Catheter Cardiovasc Interv. 2017;90(4):531-539.
Jurado-Roman A, Montero-Cabezas J, Martínez G, et al. Procedural and clinical benefits of selective thrombus aspiration in primary PCI. Insights from the TAPER registry. REC Inteventional Cardiol. 2019;3:175-182.
Ojeda S, Romaguera R, Cruz-González I, Moreno R. Registro Español de Hemodinámica y Cardiología Intervencionista. XXIX Informe Oficial de la Asociación de Cardiología Intervencionista de la Sociedad Española de Cardiología (1990-2019). Rev Esp Cardiol. 2020;73(11):927-936.
Meier D, Fournier S, Masci PG, et al. Impact of manual thrombectomy on microvascular obstruction in STEMI patients. Catheter Cardiovasc Interv. 2021;97(6):1141-1148. https://doi.org/10.1002/ccd.28907.
Marquis-Gravel G, Zeitouni M, Kochar A, et al. Technical consideration in acute myocardial infarction with cardiogenic shock: a review of antithrombotic and PCI therapies. Catheter Cardiovasc Interv. 2020;95(5):924-931.
Cordero A, Freites A, Escribano D, Bertomeu-Martínez V, Zuazola P, Badimon L. A simple score to select patients for manual thrombectomy in emergent percutaneous coronary interventions: the DDTA score. J Cardiovasc Med. 2020;21(8):595-602.
Niccoli G, Burzotta F, Galiuto L, Crea F. Myocardial no-reflow in humans. J Am Coll Cardiol. 2009;54(4):281-292.
Mancini JG, Filion KB, Windle SB, Habib B, Eisenberg MJ. Meta-analysis of the long-term effect of routine aspiration Thrombectomy in patients undergoing primary percutaneous coronary intervention. Am J Cardiol. 2016;118(1):23-31.
De Luca G, Suryapranata H, van't Hof Arnoud WJ, et al. Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty. Circulation. 2004;109(22):2737-2743.
Mehran R, Rao SV, Bhatt DL, et al. Standardized bleeding definitions for cardiovascular clinical trials. Circulation. 2011;123(23):2736-2747.
Cordero A, Garcia-Acuna JM, Rodriguez-Manero M, et al. Prevalence, long-term prognosis and medical alternatives for patients admitted for acute coronary syndromes and prasugrel contraindication. Int J Cardiol. 2018;2770(1):36-41.
Jolly SS, James S, Dzavik V, et al. Thrombus aspiration in ST-segment-elevation myocardial infarction: an individual patient meta-analysis: thrombectomy trialists collaboration. Circulation. 2017;135(2):143-152.
Spitzer E, Heg D, Stefanini GG, et al. Aspiration thrombectomy for treatment of ST-segment elevation myocardial infarction: a meta-analysis of 26 randomized trials in 11 943 patients. Rev Esp Cardiol (Engl Ed) 2015;68(9):746-752.
Frobert O, Lagerqvist B, Olivecrona GK, et al. Thrombus aspiration during ST-segment elevation myocardial infarction. N Engl J Med. 2013;369(17):1587-1597.
Jolly SS, Cairns JA, Yusuf S, et al. Randomized trial of primary PCI with or without routine manual thrombectomy. N Engl J Med. 2015;372(15):1389-1398.
Svilaas T, Vlaar PJ, van der Horst IC, et al. Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med. 2008;358(6):557-567.
Barkagan M, Steinvil A, Berchenko Y, et al. Impact of routine manual aspiration thrombectomy on outcomes of patients undergoing primary percutaneous coronary intervention for acute myocardial infarction: a meta-analysis. Int J Cardiol. 2016;204:189-195.
Sardella G, Mancone M, Bucciarelli-Ducci C, et al. Thrombus aspiration during primary percutaneous coronary intervention improves myocardial reperfusion and reduces infarct size: the EXPIRA (thrombectomy with export catheter in infarct-related artery during primary percutaneous coronary intervention) prospective, randomized trial. J Am Coll Cardiol. 2009;53(4):309-315.
Bangalore S, Toklu B, Stone GW. Meta-analysis of culprit-only versus multivessel percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction and multivessel coronary disease. Am J Cardiol. 2018;121(5):529-536.
Fabris E, Van't Hof A, Hamm CW, et al. Impact of presentation and transfer delays on complete ST-segment resolution before primary percutaneous coronary intervention: insights from the ATLANTIC trial. EuroIntervention. 2017;13(1):69-77.
Cui X, Zhou J, Pivodic A, Dahlström U, Ge J, Fu M. Temporal trends in cause-specific readmissions and their risk factors in heart failure patients in Sweden. Int J Cardiol. 2020;306:116-122.
Tommaso CL. Mechanical thrombectomy revisited is there any value? Catheter Cardiovasc Interv. 2017;90(4):540.
Cid Álvarez AB, Rodríguez Leor O, Moreno R, Pérez de Prado A. Registro Español de Hemodinámica y Cardiología Intervencionista. XXVIII Informe Oficial de la Sección de Hemodinámica y Cardiología Intervencionista de la Sociedad Española de Cardiología (1990-2018). Rev Esp Cardiol. 2019;72(12):1043-1053.
Montalescot G, van 't Hof AW, Lapostolle F, et al. Prehospital ticagrelor in ST-segment elevation myocardial infarction. N Engl J Med. 2014;371(11):1016-1027.
Rivero F, Bastante T, Cuesta J, et al. Factors associated with delays in seeking medical attention in patients with ST-segment elevation acute coronary syndrome. Rev Esp Cardiol (Engl Ed). 2016;69(3):279-285.
Jollis JG, Al-Khalidi HR, Roettig ML, et al. Regional systems of care demonstration project: American Heart Association Mission: lifeline STEMI systems accelerator. Circulation. 2016;134(5):365-374.
Cordero A, Lopez-Palop R, Carrillo P, et al. Changes in acute coronary syndrome treatment and prognosis after implementation of the infarction code in a hospital with a cardiac catheterization unit. Rev Esp Cardiol (Engl Ed). 2016;69(8):754-759.
Galvao Braga C, Cid-Alvarez AB, Redondo Dieguez A, et al. Multivessel versus culprit-only percutaneous coronary intervention in ST-segment elevation acute myocardial infarction: analysis of an 8-year registry. Rev Esp Cardiol (Engl Ed) 2017;70(6):425-432.
Bajaj NS, Ather S, Gaba S, et al. Glycoprotein IIb/IIIa inhibitors improve mortality after aspiration thrombectomy in patients with ST-segment elevation myocardial infarction. Int J Cardiol. 2015;187:206-207.
Hammas S, Veugeois A, Caussin C, Amabile N. Analysis of residual thrombotic burden after thrombus aspiration in acute ST elevation myocardial infarction: an optical coherence tomographic evaluation. Int J Cardiol. 2015;181:351-352.
Stanek F, Ouhrabkova R, Prochazka D. Could mechanical thrombectomy replace thrombolysis in the treatment of acute and subacute limb ischemia? Minerva Cardioangiol. 2019;67(3):234-245.
Einarsson F, Sandström C, Svennerholm K, Oras J, Rylander C. Outcomes of catheter-directed interventions in high-risk pulmonary embolism-a retrospective analysis. Acta Anaesthesiologica Scandinavica. 2021;65(4):499-506.